Europe Advanced Wound Care Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Europe Advanced Wound Care Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The European advanced wound care market is expected to register a healthy CAGR of nearly 6.1% during the forecast period of 2022-2027.

The COVID-19 pandemic was expected to have a significant impact on the market. A study titled "Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data", published in December 2020, reported that the new coronavirus strain almost tripled its number of infections in England. Hence, the United Kingdom and many other countries in Europe were seeing localized lockdowns, with Governments imposing travel restrictions, etc. With the lockdown being imposed, elective surgeries were held up again, which was expected to have a negative impact on the market. Governments have taken various definite measures to provide proper wound care management for the population. For instance, a research paper named "Wound Antiseptics and European Guidelines for Antiseptic Application in Wound Treatment" released in December 2021 noted that chronic wound infections afflict roughly 1.5% of the population and that problems with wound healing are highly prevalent. Antiseptics are the primary materials used in wound washing, cleaning, and therapy. Only the following antiseptics should be considered for wound treatment, according to the recommendations of the Polish Society for Wound Treatment and the German Consensus on Wound Antisepsis: octenidine (OCT), polihexanide (PHMB), povidone-iodine (PVP-I), sodium hypochlorite (NaOCl), and nanosilver. Such instances are expected to support the European advanced wound care market during the COVID-19 pandemic.

The major factors that are expected to drive the European advanced wound care market’s growth include the high and increasing burden of chronic diseases, a high number of surgeries, and a rising geriatric population along with other risk factors. For instance, according to an article published in June 2021, titled "German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery," there were approximately 29,444 isolated coronary artery bypass grafting procedures, 35,469 isolated heart valve procedures, and 843 assist device implantations (including left/right/biventricular assist devices, total artificial devices) registered in Germany. According to the same source, the number of solitary heart transplants in Germany has surged to 340, a 2.1% increase over the previous year. Hence, an increasing number of surgeries are expected to play a significant role in the European advanced wound care market over the forecast period. In addition, according to the International Diabetes Federation in 2021 report, the estimated prevalence of diabetes in adults of age 20-79 years in Europe was 61.4 million in 2021, and this prevalence is projected to reach 69 million by 2045. The increasing incidences of diabetes may further lead to growth in this market because diabetes slows down the healing process making diabetic people more prone to infections and other complications.

Furthermore, the companies operating in the advanced wound care market in Europe are progressive and continuously innovating their products and launching them in the market which is further expected to augment the growth of the studied market. For instance, in November 2020, Advanced Medical Solutions, a surgical and advanced wound care specialist company based in the United Kingdom, received a Conformitè Europëenne (CE) mark for its product “Silicone PHMB Foam Dressing.” In June 2021, RLS Global, a medical healthcare company based in Sweden, and ConvaTec signed a global collaboration agreement to commercialize ChloraSolv which will be included in ConvaTec’s Wound Hygiene Protocol of care for hard-to-heal wounds. Hence, such product launches are expected to drive the market. Thus, the abovementioned factors are anticipated to fuel growth in the advanced wound care market in Europe. However, the high cost associated with the treatment and reimbursement issues for the new technologies is the major factors that are expected to impede the market’s growth over the forecast period.

Key Market TrendsUnder Wound Dressings, Foam Dressings are Projected to Register Significant Growth

Foam dressing is a highly absorbent dressing used for wound care. Foam dressings need less changing dressings when compared to other types of dressings. The advantage of foam dressings is that foam help in maintaining a moist wound environment. Also, the foam helps cushion the wound and peri-wound area from additional trauma and provides thermal insulation for wounds.

Furthermore, these dressings are easy to remove and cause less trauma, hence widely used in most wound dressings. Lower extremities chronic ulcers, in particular those linked to diabetes, venous disease, or arterial disease Thus, it is anticipated that as diabetes rates rise, the number of ulcer cases requiring advanced wound care will also rise. Thus, it is anticipated that the market will develop as diabetes rates rise.

In addition to this, advancements in products and new launches are expected to boost the segment growth over the forecast period. For instance, in November 2020, Advanced Medical Solutions (AMS), a surgical and advanced wound care specialist company, received a Conformitè Europëenne (CE) mark for its product “Silicone PHMB Foam Dressing.” It is a polyurethane foam impregnated with Polyhexamethylene Biguanide along with an atraumatic perforated silicone wound contact layer. Hence, owing to the aforementioned factors, the market for foam dressings is expected to have significant growth over the forecast period.

Moreover, In October 2021, Germany’s Covestro initiated the European Union (EU) project to research the recycling of polyurethane (PU) foams. The Circular Foam project involves 22 partners from nine EU countries. The project will also save EUR 150 million/year in PU incineration costs. Hence, such initiatives are expected to increase market growth by reducing the cost of raw materials. Thus, the abovementioned factors are expected to increase market growth.

France is Expected to Dominate the Market Over the Forecast Period

The rise in the number of chronic diseases such as diabetes in France is expected to augment the demand for wound dressing products in the country as surgical wounds are more frequently managed with wound dressings.

The increasing incidences of diabetes may further lead to growth in this market. The growing prevalence of several lifestyle disorders leading to chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, is one of the key factors estimated to encourage the growth of the advanced wound care market in the coming years. As per the report of the International Diabetes Foundation 2021 report, about 3.94 million adults of age 20-79 years were living with diabetes in France in 2021 and their number is estimated to increase to 4.23 million by 2045. Hence, a high number of the diabetic population indicates the chances of a rise in diabetes-related ulcers or wounds, which is believed to propel the growth of the French advanced wound care market.

Product launches are another factor in market growth. For instance, in January 2022, Accel-Heal was launched in France. Accel-Heal facilitates the wider adoption of electrical stimulation wound therapy. The 12-day therapy is designed to be used by patients in the comfort and convenience of their own homes. Accel-Heal is suitable for use with existing dressing regimes and can be applied to all types of chronic wounds including difficult-to-dress wounds such as diabetic foot ulcers. Hence, due to the abovementioned factors, the market is likely to increase in the future.

Competitive Landscape

The advanced wound care market is significantly fragmented, with the presence of a large number of players. As technology progresses and becomes more viable, the quality of life of patients afflicted with chronic wounds improves. The major players that currently dominate the market include Coloplast AS, Integra Lifesciences, ConvaTec Group PLC, Smith & Nephew and Paul Hartmann AG. Market players are focusing on various growth strategies, in order to enhance the market presence by mergers, acquisitions, partnerships, collaborations, new product launches, etc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.